More than 50 biotech startups are located at the Biotechnology Innovation and Startup Center in Martinsried, just outside Munich. As of October 1, the European investor Andera Partners also moved into the IZB. The investor has a 15-person life sciences team and extensive experience in the life sciences industry. Since its launch, the investor has raised more than €1.1 billion for over 75 European and American biotech and medtech companies through its Biodiscovery fund family. Andera Partners is currently investing from its new fund, Biodiscovery 6. The IZB startup is one of Andera Partners' portfolio companies. Tubules.
IZB: “Leading biotechnology location in Germany and Europe”
Peter Hanns Zobel, Managing Director of the IZB, says:
"We are delighted to welcome Andera Partners to the IZB. The presence of this important European life sciences investor on our campus underpins our position as a leading biotechnology location in Germany and Europe. I am confident that this will create interesting synergies that will benefit both the startups based here and Andera."
The investor invests in companies that develop groundbreaking therapeutic products and medical technologies from the preclinical phase to commercialization, says Olivier Litzka, now a Munich-based partner at Andera:
"Our company focuses on developing innovative medical solutions based on solid scientific hypotheses, supported by preclinical or clinical data, and protected by strong intellectual property. Andera takes an active role in its investments and supports talented entrepreneurs who consistently advance their innovations. I very much look forward to a lively exchange in the environment of the IZB, Martinsried, and Munich."
